Cognition Therapeutics, Inc. (CGTX)
1.21
+0.07
(+6.14%)
USD |
NASDAQ |
Jun 11, 13:54
Cognition Therapeutics 1 Year Total Returns (Daily) : 263.1% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | 263.1% |
| June 09, 2026 | 280.4% |
| June 08, 2026 | 309.8% |
| June 05, 2026 | 344.7% |
| June 04, 2026 | 342.1% |
| June 03, 2026 | 358.2% |
| June 02, 2026 | 325.9% |
| June 01, 2026 | 423.0% |
| May 29, 2026 | 374.7% |
| May 28, 2026 | 388.5% |
| May 27, 2026 | 360.3% |
| May 26, 2026 | 317.6% |
| May 22, 2026 | 300.0% |
| May 21, 2026 | 292.7% |
| May 20, 2026 | 281.4% |
| May 19, 2026 | 236.4% |
| May 18, 2026 | 235.2% |
| May 15, 2026 | 261.8% |
| May 14, 2026 | 259.8% |
| May 13, 2026 | 273.6% |
| May 12, 2026 | 261.0% |
| May 11, 2026 | 291.9% |
| May 08, 2026 | 266.7% |
| May 07, 2026 | 227.0% |
| May 06, 2026 | 194.6% |
| Date | Value |
|---|---|
| May 05, 2026 | 185.2% |
| May 04, 2026 | 187.1% |
| May 01, 2026 | 186.2% |
| April 30, 2026 | 195.2% |
| April 29, 2026 | 182.8% |
| April 28, 2026 | 207.3% |
| April 27, 2026 | 192.4% |
| April 24, 2026 | 190.0% |
| April 23, 2026 | 229.0% |
| April 22, 2026 | 242.1% |
| April 21, 2026 | 221.8% |
| April 20, 2026 | 200.8% |
| April 17, 2026 | 219.5% |
| April 16, 2026 | 197.4% |
| April 15, 2026 | 184.4% |
| April 14, 2026 | 147.6% |
| April 13, 2026 | 176.1% |
| April 10, 2026 | 183.2% |
| April 09, 2026 | 163.0% |
| April 08, 2026 | 174.4% |
| April 07, 2026 | 135.6% |
| April 06, 2026 | 136.5% |
| April 02, 2026 | 110.2% |
| April 01, 2026 | 127.3% |
| March 31, 2026 | 80.49% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Verrica Pharmaceuticals, Inc. | -4.33% |
| ANI Pharmaceuticals, Inc. | 30.19% |
| Corcept Therapeutics, Inc. | 8.09% |
| Assertio Holdings, Inc. | 136.8% |
| Veru, Inc. | -55.88% |